5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid has been researched along with Xeroderma in 1 studies
5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid: RN given refers to (S-(R*,R*-(E,E,Z,Z)))-isomer
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Willemsen, MA | 1 |
| IJlst, L | 1 |
| Steijlen, PM | 1 |
| Rotteveel, JJ | 1 |
| de Jong, JG | 1 |
| van Domburg, PH | 1 |
| Mayatepek, E | 1 |
| Gabreëls, FJ | 1 |
| Wanders, RJ | 1 |
1 review available for 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid and Xeroderma
| Article | Year |
|---|---|
Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome.
Topics: Adolescent; Adult; Aldehyde Oxidoreductases; Brain; Cells, Cultured; Cerebrospinal Fluid; Child; Chi | 2001 |